MetaCap

OrthoPediatrics (KIDS) vs Senseonics (SENS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

OrthoPediatrics (KIDS) has outperformed Senseonics (SENS) over the past year, gaining 20.2% versus a loss of 2.4%. Over five years, KIDS leads with a -65.4% price change compared with -86.3% for SENS. OrthoPediatrics is the larger company by market cap ($565.3 million vs $474.8 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KIDS+20.22%SENS-2.38%
+51%-0%-52%
Oct 8, 20251 yearOct 8, 2026
KIDS-63.29%SENS-85.91%
+29%-35%-98%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KIDS versus SENS key metrics
MetricKIDSSENS
Share price$21.65$8.98
Market cap$565.28M$474.81M
1-day change-0.51%-0.44%
YTD return+22.52%+63.41%
1-year return+20.22%-2.38%
5-year return-65.42%-86.33%
EPS (TTM)$-1.68$-2.23
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$26.74$10.64
52-week low$14.42$4.79
Distance from 52-week high-19.04%-15.60%
Analyst consensusnonebuy
Avg. price target upside+25.73%+50.33%
Average volume209.38K681.53K
Shares outstanding26.11M52.87M
Employees602130
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • KIDS has outperformed SENS by 22.6 percentage points over the past year.

About OrthoPediatrics

KIDS stock →

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.

Health Care · Medical/Dental Instruments · 602 employees

About Senseonics

SENS stock →

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.

Health Care · Medical/Dental Instruments · 130 employees

KIDS vs SENS FAQ

Which is bigger, OrthoPediatrics or Senseonics?

OrthoPediatrics (KIDS) is larger, with a market capitalization of $565.28M compared with $474.81M for Senseonics (SENS).

Which stock has performed better over the past year, KIDS or SENS?

KIDS returned +20.22% over the past 12 months, compared with -2.38% for SENS (price return, excluding dividends). Past performance does not predict future results.

Are OrthoPediatrics and Senseonics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons